NCT04513028View on ClinicalTrials.gov

Beta Glucan's Effect on Pembrolizumab Immunologic Response in Stage III-IV Melanoma

NARecruitingINTERVENTIONAL

Enrollment

30

Participants

Timeline

Start Date

November 3, 2020

Primary Completion Date

July 31, 2025

Study Completion Date

July 31, 2026

Conditions

Melanoma Stage IIIMelanoma Stage IV

Interventions

DIETARY_SUPPLEMENT

Beta-Glucan

500mg (1 capsule) by mouth twice a day for 21 days.

Trial Locations (1)

40202

RECRUITING

University of Louisville, Louisville

All Listed Sponsors

lead

Kelly McMasters

OTHER